Arbutus Biopharma Corp

Arbutus Biopharma Corp

ABUS

Get informed when a big investor buys or sells

+ Follow
Market Cap$948.18M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Arbutus Biopharma CorpArbutus Biopharma Corp5.8-62%--
$-3.04

Current Fair Value

166% downside

Overvalued by 166% based on the discounted cash flow analysis.

Share Statistics

Market cap$948.18 Million
Enterprise Value$925.11 Million
Dividend Yield$- (-)
Earnings per Share$-0.17
Beta0.62
Outstanding Shares193,768,641

Return

Return on Equity61.77%ROE
Return on Assets57.99%
Return on Invested Capital57.10%

Valuation & Multiples

P/E Ratio5.76P/E Ratio
PEG-0.73PEG
Price to Sales-Price to Sales
Price to Book Ratio4.61Price to Book Ratio
Enterprise Value to Revenue4.83
Enterprise Value to EBIT5.95
Enterprise Value to Net Income5
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.03
Average shareholder expectation
Revenue Estimate
$750,000
Average shareholder expectation

Next Earnings Call

Expected Date
July 30, 2026
EPS Estimate
$-0.03
Average shareholder expectation
Revenue Estimate
$650,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 108.95%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.15%▼ 72.39%
Total Invested$1.36M▼ 99.78%
Investors Holding4▼ 171.00%

ESG Score

No data

About Arbutus Biopharma Corp

CEO: William Collier